Bifidobacterium breve Bif195 Protects Against Small-intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers.
- 2019-09
- RCT · n = 75
- Gastroenterology 157(3)
- Brynjulf Mortensen
- C. Murphy
- J. O’Grady
- M. Lucey
- G. Elsafi
- L. Barry
- V. Westphal
- A. Wellejus
- O. Lukjancenko
- A. Eklund
- H. Nielsen
- Adam Baker
- A. Damholt
- J. V. H. van Hylckama Vlieg
- F. Shanahan
- M. Buckley
- PubMed: 31095949
- DOI: 10.1053/j.gastro.2019.05.008
- High evidence
Twelve adverse events were reported from the Bif195 group and 20 from the placebo group. None of the events was determined to be related to Bif195 intake.
- Effect
- Neutral
- Effect size
- Moderate